Bahrain approves Chinese COVID-19 vaccine for front-line workers - Al-Monitor: The Middle Eastʼs leading independent news source since 2012

Al-Monitor Staff

Al-Monitor Staff

Nov 3, 2020

A picture shows the Manama's repurposed convention centre, in which 6,000 people are participating in a large-scale trial of a Chinese-sponsored vaccine for the Covid-19 coronavirus, on August 27, 2020 in the Bahraini capital. - Chinese drug giant Sinopharm began testing the inactivated COVID-19 jab in Bahrain earlier this month after starting a similar trial on 15,000 subjects in the nearby United Arab Emirates in July. The current phase of the study, in which the vaccine's efficacy and safety is tested in — A picture shows Manama's repurposed convention center, in which 6,000 people are participating in a large-scale trial of a Chinese-sponsored vaccine for the novel coronavirus, on Aug. 27, 2020, in the Bahraini capital. — MAZEN MAHDI/AFP via Getty Images

Bahrain’s Health Ministry has approved a coronavirus vaccine for emergency use on front-line health workers, the state news agency BNA reported Tuesday.

"The results of Phase I and Phase II clinical trials showed the vaccine is safe and effective," Bahrain's Health Minister Faeqa bint Saeed Al Saleh said on Tuesday, according to Reuters.

Related Topics

Coronavirus

BEIJING, CHINA - SEPTEMBER 24: Syringes and boxes of the potential COVID-19 vaccine CoronaVac are seen on a table at Sinovac Biotech where the company is producing their potential COVID-19 vaccine CoronaVac during a media tour on September 24, 2020 in Beijing, China. Sinovacs inactivated vaccine candidate, called CoronaVac, is among a number of companies in the global race to control the coronavirus pandemic. The company is running Phase 3 human trials in four countries and ramping up production to 300 m

China looks to boost its GCC interests with 'vaccine diplomacy'

Sabena Siddiqui

Sabena Siddiqui

In Karachi, reporting on South Asia, Middle East, Iran

In this picture taken on April 29, 2020, an engineer takes samples of monkey kidney cells as he make tests on an experimental vaccine for the COVID-19 coronavirus inside the Cells Culture Room laboratory at the Sinovac Biotech facilities in Beijing. - Sinovac Biotech, which is conducting one of the four clinical trials that have been authorised in China, has claimed great progress in its research and promising results among monkeys. (Photo by NICOLAS ASFOURI / AFP) / TO GO WITH Health-virus-China-vaccine,FO

Why Egypt chose Chinese COVID-19 vaccine over Russian one

A correspondent in Egypt

A correspondent in Egypt

How Egypt became hub for Russian COVID-19 vaccine

Hagar Hosny

Hagar Hosny

A nurse prepares to inoculate volunteer Ilya Dubrovin, 36, with Russia's new coronavirus vaccine in a post-registration trials at a clinic in Moscow on September 10, 2020. - Russia announced last month that its vaccine, named "Sputnik V" after the Soviet-era satellite that was the first launched into space in 1957, had already received approval. The vaccine was developed by the Gamaleya research institute in Moscow in coordination with the Russian defence ministry. (Photo by Natalia KOLESNIKOVA / AFP) (Phot

Iran, Russia discuss producing COVID-19 vaccine

Al-Monitor Staff

Al-Monitor Staff